Written and medically reviewed by Dorcas Morak, Pharm.D
Chronic Obstructive Pulmonary Disease (COPD) is an umbrella term for progressive lung diseases—primarily emphysema and chronic bronchitis—that make it harder to move air in and out of the lungs. It remains a leading cause of death in the U.S., and millions remain undiagnosed because early symptoms are often mistaken for “getting older” or seasonal allergies.
Every November, COPD Awareness Month highlights the importance of early diagnosis, consistent follow-up, and practical strategies to help people breathe easier, prevent flare-ups, and afford the medications they need.
What COPD Feels Like—and Who’s at Risk
COPD often develops slowly, so early recognition matters. A simple office evaluation called spirometry can confirm the diagnosis and guide treatment before lung damage worsens.
Common symptoms:
- Shortness of breath (especially with activity)
- Chronic cough
- Wheezing
- Chest tightness
- Excess mucus or phlegm
Tracking daily activities—such as how many stairs you can climb—can help you spot subtle changes sooner.
Key risk factors:
- Cigarette smoking and secondhand smoke
- Long-term exposure to air pollution, dust, or workplace chemicals
- Frequent childhood respiratory infections
- Genetics, including alpha-1 antitrypsin deficiency
Which Medications Are Used for COPD Management?
Treatment typically combines rescue inhalers for sudden symptoms and maintenance therapies for long-term control.
Rescue (as-needed) inhalers:
- Albuterol (Ventolin, ProAir, Proventil)
- Levalbuterol (Xopenex)
Maintenance inhalers (daily):
- Long-acting beta2-agonists (LABAs): salmeterol (Serevent), formoterol (Perforomist)
- Long-acting muscarinic antagonists (LAMAs): tiotropium (Spiriva), umeclidinium (Incruse Ellipta), aclidinium (Tudorza)
- Inhaled corticosteroids (ICS): fluticasone (Flovent), budesonide (Pulmicort)
- Combination inhalers: fluticasone/umeclidinium/vilanterol (Trelegy Ellipta), budesonide/formoterol (Symbicort), tiotropium/olodaterol (Stiolto Respimat)
Other options:
- Roflumilast (Daliresp): for chronic bronchitis with repeated flare-ups
- Azithromycin: sometimes used long-term in select patients with frequent exacerbations
- Systemic treatments for flare-ups: short courses of oral steroids (prednisone) and antibiotics when appropriate
Supportive therapies:
- Oxygen therapy for patients with low oxygen levels
- Pulmonary rehabilitation to improve stamina and breathing technique Tip: Medication costs can add up quickly, especially for combination inhalers. The RxLess® Assurance Plan helps patients compare real-time pharmacy prices nationwide and save on prescriptions with or without insurance.
Are There Emerging Management Options?
Research continues into new anti-inflammatory pathways—such as p38 MAPK inhibitors like losmapimod—and biologics that target specific immune processes. Some clinical trials are also exploring cell-based therapies. While promising, these remain experimental and are only available in specialist or trial settings.
Everyday Management Strategies for COPD
Quit smoking: The single most powerful step to slow progression.
Stay current on vaccines:
- Annual flu shot
- COVID-19 booster
- Pneumococcal vaccines (PCV20, PPSV23)
- RSV vaccine (for adults =60, when recommended)
Pulmonary rehabilitation: Structured programs improve exercise tolerance, teach energy-conserving breathing (like pursed-lip breathing), and reduce hospitalizations.
Be active—safely: Light aerobic activity and strength training improve stamina. A rehab team can tailor a plan if you’re deconditioned.
Nutrition and sleep: Maintain a healthy weight—underweight patients may need high-protein, small meals. Prioritize restful sleep, as fatigue worsens breathlessness.
Address comorbidities: Heart disease, diabetes, depression, and anxiety frequently overlap with COPD and require coordinated care.
Use technology: Pulse oximeters, smartphone inhaler reminders, and digital symptom trackers can help patients stay on top of their health.
Have an action plan: Recognize your flare-up warning signs, keep rescue meds nearby, and call your clinician promptly for worsening symptoms.
What’s New in COPD Awareness for 2025?
This year’s focus goes beyond lung function numbers to embrace whole-person wellness:
- Encouraging conversations about mood, sleep, and social support
- Building personalized COPD action plans
- Expanding access to telehealth pulmonary rehab
- Promoting affordable medication access through programs like the RxLess® Assurance Plan
- Addressing inequities by increasing screenings and resources in communities hardest hit by respiratory illness
When Should You Talk to a Clinician?
Reach out promptly if you notice:
- Worsening breathlessness, reduced walking distance, or new wheezing
- Increased cough, thicker/greener mucus, or fever
- Trouble using your inhaler correctly (a quick technique check can make a big difference)
- Side effects from medications, such as hoarseness or oral thrush from inhaled steroids (using a spacer and rinsing after use helps)
Final Takeaway
COPD may be a lifelong condition, but with early diagnosis, effective treatments, healthy lifestyle choices, and cost-saving resources, people can live more actively and comfortably. This COPD Awareness Month, talk with your provider about lung health—and explore savings with the RxLess® Assurance Plan so your treatment is affordable and sustainable.
